Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 21 April 2000:
Vol. 288. no. 5465, pp. 410 - 411
DOI: 10.1126/science.288.5465.410
Prev | Table of Contents | Next

News of the Week

SCIENCE AND BUSINESS:
Patent Prompts Rochester to Sue for Slice of Drug Profits

David Malakoff

Last week, after an 8-year review, the U.S. Patent and Trademark Office gave the University of Rochester in New York a sweeping patent on the science underlying a new class of anti-inflammatory drugs known as COX-2 inhibitors. The market for such drugs is estimated at $10 billion by 2008. Within hours of the 11 April award, Rochester officials filed suit against the makers of a top-selling drug based on the discovery.

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Academic Relationships With Industry: A New Model for Biomedical Research.
H. Moses III and J. B. Martin (2001)
JAMA 285, 933-935
   Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)